
Hillo is a development of tools for continuous blood glucose monitoring. The company provides services for the medical industry.

Hillo is a development of tools for continuous blood glucose monitoring. The company provides services for the medical industry.
Domain: hillo.ai
Headquarters: Palaiseau / Igny, Île-de-France, France
Founded: 2016
Focus: AI-based digital twins and continuous glucose monitoring for diabetes care
Employees (approx.): 55
Total funding: USD 2,370,000 (as of 2020-03-01)
Diabetes management; continuous blood glucose monitoring and personalized glycemic response prediction.
2016
Healthtech / Medical AI
USD 2,370,000
“Investors reported include NCI Waterstart, Angels Santé, Wille Finance and INSEAD Business Angels Alumni France.”